FREE SHIPPING ON ORDERS OVER $150

kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Supplementing Glycine and N-Acetylcysteine (GlyNAC)

$24.77

Quantity
- +
Description

doi: 10.1186/1477-7827-11-48 18 HerwigRKnollCPlanyavskyMPourbiabanyAGreilbergerJBennettKL

kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Supplementing Glycine and N-Acetylcysteine (GlyNAC)

"Frailty consensus: a call to action"

kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Supplementing Glycine and N-Acetylcysteine (GlyNAC)

10.1016/j.drudis.2020.12.005 7 BangashM

kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Supplementing Glycine and N-Acetylcysteine (GlyNAC)

Trushin SA, Carena AA, Bren GD, Rizza SA, Dong X, Abraham RS et al

kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Supplementing Glycine and N-Acetylcysteine (GlyNAC)

You may also like

recommand products